BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 25956683)

  • 1. Wnt5a attenuates hypoxia-induced pulmonary arteriolar remodeling and right ventricular hypertrophy in mice.
    Jin Y; Wang W; Chai S; Liu J; Yang T; Wang J
    Exp Biol Med (Maywood); 2015 Dec; 240(12):1742-51. PubMed ID: 25956683
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Wnt5a inhibits hypoxia-induced pulmonary arterial smooth muscle cell proliferation by downregulation of β-catenin.
    Yu XM; Wang L; Li JF; Liu J; Li J; Wang W; Wang J; Wang C
    Am J Physiol Lung Cell Mol Physiol; 2013 Jan; 304(2):L103-11. PubMed ID: 23144322
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bioactive fraction of Rhodiola algida against chronic hypoxia-induced pulmonary arterial hypertension and its anti-proliferation mechanism in rats.
    Nan X; Su S; Ma K; Ma X; Wang X; Zhaxi D; Ge R; Li Z; Lu D
    J Ethnopharmacol; 2018 Apr; 216():175-183. PubMed ID: 29325918
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hydroxysafflor yellow A (HSYA) attenuates hypoxic pulmonary arterial remodelling and reverses right ventricular hypertrophy in rats.
    Li L; Dong P; Hou C; Cao F; Sun S; He F; Song Y; Li S; Bai Y; Zhu D
    J Ethnopharmacol; 2016 Jun; 186():224-233. PubMed ID: 27063983
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Involvement of CapG in proliferation and apoptosis of pulmonary arterial smooth muscle cells and in hypoxia-induced pulmonary hypertension rat model.
    Xu X; Hu H; Wang X; Ye W; Su H; Hu Y; Dong L; Zhang R; Ying K
    Exp Lung Res; 2016 Apr; 42(3):142-53. PubMed ID: 27093378
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aqp-1 Gene Knockout Attenuates Hypoxic Pulmonary Hypertension of Mice.
    Liu M; Liu Q; Pei Y; Gong M; Cui X; Pan J; Zhang Y; Liu Y; Liu Y; Yuan X; Zhou H; Chen Y; Sun J; Wang L; Zhang X; Wang R; Li S; Cheng J; Ding Y; Ma T; Yuan Y
    Arterioscler Thromb Vasc Biol; 2019 Jan; 39(1):48-62. PubMed ID: 30580569
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tsantan Sumtang Alleviates Chronic Hypoxia-Induced Pulmonary Hypertension by Inhibiting Proliferation of Pulmonary Vascular Cells.
    He Q; Nan X; Li S; Su S; Ma K; Li Z; Lu D; Ge R
    Biomed Res Int; 2018; 2018():9504158. PubMed ID: 30622966
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dominant negative mutation of the TGF-beta receptor blocks hypoxia-induced pulmonary vascular remodeling.
    Chen YF; Feng JA; Li P; Xing D; Zhang Y; Serra R; Ambalavanan N; Majid-Hassan E; Oparil S
    J Appl Physiol (1985); 2006 Feb; 100(2):564-71. PubMed ID: 16223981
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cystamine Treatment Fails to Prevent the Development of Pulmonary Hypertension in Chronic Hypoxic Rats.
    Markvardsen LK; Sønderskov LD; Wandall-Frostholm C; Pinilla E; Prat-Duran J; Aalling M; Mogensen S; Andersen CU; Simonsen U
    J Vasc Res; 2021; 58(4):237-251. PubMed ID: 33910208
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of LRP5/6-mediated Wnt/β-catenin signaling by Mesd attenuates hyperoxia-induced pulmonary hypertension in neonatal rats.
    Alapati D; Rong M; Chen S; Lin C; Li Y; Wu S
    Pediatr Res; 2013 Jun; 73(6):719-25. PubMed ID: 23481549
    [TBL] [Abstract][Full Text] [Related]  

  • 11. mTORC1 is involved in hypoxia-induced pulmonary hypertension through the activation of Notch3.
    Wang W; Liu J; Ma A; Miao R; Jin Y; Zhang H; Xu K; Wang C; Wang J
    J Cell Physiol; 2014 Dec; 229(12):2117-25. PubMed ID: 24825564
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The potential of asiaticoside for TGF-β1/Smad signaling inhibition in prevention and progression of hypoxia-induced pulmonary hypertension.
    Wang XB; Wang W; Zhu XC; Ye WJ; Cai H; Wu PL; Huang XY; Wang LX
    Life Sci; 2015 Sep; 137():56-64. PubMed ID: 26209140
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drag-reducing polymers attenuates pulmonary vascular remodeling and right ventricular dysfunction in a rat model of chronic hypoxia-induced pulmonary hypertension.
    Wang Y; Wu F; Hu F; Wu Y; Zhou J; Xu Y; Shao X; Hu T
    Clin Hemorheol Microcirc; 2020; 74(2):189-200. PubMed ID: 31476149
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Iron is associated with the development of hypoxia-induced pulmonary vascular remodeling in mice.
    Naito Y; Hosokawa M; Sawada H; Oboshi M; Iwasaku T; Okuhara Y; Eguchi A; Nishimura K; Soyama Y; Hirotani S; Mano T; Ishihara M; Masuyama T
    Heart Vessels; 2016 Dec; 31(12):2074-2079. PubMed ID: 27311944
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exosomes derived from mesenchymal stromal cells exert a therapeutic effect on hypoxia-induced pulmonary hypertension by modulating the YAP1/SPP1 signaling pathway.
    Chen YX; Deng ZH; Xue-Gao ; Qiang-Du ; Juan-Yin ; Chen GH; Li JG; Zhao YM; Zhang HT; Zhang GX; Qian JX
    Biomed Pharmacother; 2023 Dec; 168():115816. PubMed ID: 37918254
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quercetin reverses experimental pulmonary arterial hypertension by modulating the TrkA pathway.
    He Y; Cao X; Liu X; Li X; Xu Y; Liu J; Shi J
    Exp Cell Res; 2015 Nov; 339(1):122-34. PubMed ID: 26476374
    [TBL] [Abstract][Full Text] [Related]  

  • 17. AntagomiR directed against miR-20a restores functional BMPR2 signalling and prevents vascular remodelling in hypoxia-induced pulmonary hypertension.
    Brock M; Samillan VJ; Trenkmann M; Schwarzwald C; Ulrich S; Gay RE; Gassmann M; Ostergaard L; Gay S; Speich R; Huber LC
    Eur Heart J; 2014 Dec; 35(45):3203-11. PubMed ID: 22450430
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dissociation of pulmonary vascular remodeling and right ventricular pressure in tissue angiotensin-converting enzyme-deficient mice under conditions of chronic alveolar hypoxia.
    van Suylen RJ; Aartsen WM; Smits JF; Daemen MJ
    Am J Respir Crit Care Med; 2001 Apr; 163(5):1241-5. PubMed ID: 11316665
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sulfur dioxide attenuates hypoxia-induced pulmonary arteriolar remodeling via Dkk1/Wnt signaling pathway.
    Luo L; Hong X; Diao B; Chen S; Hei M
    Biomed Pharmacother; 2018 Oct; 106():692-698. PubMed ID: 29990860
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deficiency of Akt1, but not Akt2, attenuates the development of pulmonary hypertension.
    Tang H; Chen J; Fraidenburg DR; Song S; Sysol JR; Drennan AR; Offermanns S; Ye RD; Bonini MG; Minshall RD; Garcia JG; Machado RF; Makino A; Yuan JX
    Am J Physiol Lung Cell Mol Physiol; 2015 Jan; 308(2):L208-20. PubMed ID: 25416384
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.